{"disease":{"id":"tp53-gene-mutation","name":"tp53 gene mutation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04541654","title":"Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT06521684","title":"Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT05735717","title":"MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT07511062","title":"Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":32,"lead_sponsor_name":"Northside Hospital, Inc.","has_results":false},{"nct_id":"NCT04976439","title":"Patogenic Mutation in 5 Genes","phase":"","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Dr Cipto Mangunkusumo General Hospital","has_results":false},{"nct_id":"NCT03149679","title":"The p53 Colorectal Cancer Trial","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"Haukeland University Hospital","has_results":false},{"nct_id":"NCT02432963","title":"Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":11,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT03272633","title":"Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies","phase":"EARLY_PHASE1","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":true}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}